Acute generalized exanthematous pustulosis: Difference between revisions
ClaireLewis (talk | contribs) |
No edit summary |
||
| Line 24: | Line 24: | ||
*[[Erythroderma]] | *[[Erythroderma]] | ||
*[[Toxic Shock Syndrome]] | *[[Toxic Shock Syndrome]] | ||
*[[Drug | *[[Drug rash]] | ||
*[[DRESS syndrome]] | *[[DRESS syndrome]] | ||
Revision as of 17:36, 31 October 2019
Background
- T-cell mediated rash with systemic features
- >90% of cases attributable to a medication (usually an antibiotic)
- Mortality rate of ~5%
Clinical Features
- Onset 1-5 days after starting causative medication
- Rash:
- Large areas of edematous erythema with numerous small, non-follicular pustules
- Predominantly affects main body folds and upper trunk, but can involve face
- NO mucous membrane involvement (in contrast to SJS/TEN)
- Systemic findings:
- Fever
- Leukocytosis, specifically neutrophilia
- +/- Facial swelling
- +/- Hepatitis
- +/- Eosinophilia
Differential Diagnosis
- Erythema Multiforme
- Stevens-Johnson syndrome and toxic epidermal necrolysis
- Staphylococcal scalded skin syndrome
- Erythroderma
- Toxic Shock Syndrome
- Drug rash
- DRESS syndrome
Evaluation
- Clinical diagnosis
- CBC
- BMP
- LFTs
Management
- Stop inciting agent
- IVF- treat similar to fluid resuscitation in burns
- Wound care, infection control
Disposition
- Admit
